Accera selects Kunze as chief executive

BROOMFIELD – Accera Inc., a developer of therapeutic treatments for neurodegenerative diseases, appointed Holger Kunze as chief executive and member of the company’s board of directors.

Kunze replaces Claude Nash who became chairman of the company’s board of directors.

Kunze has more than 30 years experience with multinational pharmaceutical and nutrition companies, most recently as regional business unit head for Nestle Health Science’s HealthCare in the Africa, Oceania and Asia territories.

Before working at Nestle, Kunze was a regional manager for Novartis Pharmaceuticals Corp. During his 10-year tenure with Novartis, Kunze established the Asia regional medical nutrition office in Singapore and managed the medical nutrition business for Novartis in 17 Asian countries.

“I am thrilled to have the opportunity to add to Accera’s efforts of providing Alzheimer’s patients with an alternative for managing their disease,” Kunze said. “I’m confident that with my experience, we’ll be able to further expand the commercial presence of Axona in global markets.”

Axona is a prescription-only medical food intended for clinical dietary management of mild to moderate Alzheimer’s disease.

on Facebook on LinkedIn